Patient with BRAF mutation under kinase inhibitor therapy and controlled systemic disease developing 3 asymptomatic 1-2cm large brain metastases

Date 10 September 2017
Event ESMO 2017 Congress
Session Treating patients with melanoma brain metastases
Topics Cytotoxic agents
Skin cancers
Biological therapy
Presenter Paolo Ascierto
Authors P.A. Ascierto
  • Melanoma, Cancer Immunotherapy And Innovative Therapy Unit, Istituto Nazionale Tumori – I.R.C.C.S - Fondazione Pascale, 80131 - Naples/IT